Xin Wang is listed as an executive officer and director on 2 SEC Form D filings by 2 issuers between Mar 2009 and Jan 2024: KONGZHONG CORP (Beijing, China (as filed: F4) — other technology — 2009; $6.78M reported sold to 1 investors) and Meihua International Medical Technologies Co., Ltd. (Yangzhou, China (as filed: F4) — other health care — 2024; $5.58M reported sold to 2 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $12.4M sold in total.
Listed alongside Hope Ni (1 shared filing), Huijuan Zhao (1 shared filing), Jay Chang (1 shared filing), Leilei Wang (1 shared filing), Lianzhang Zhao (1 shared filing) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Xin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 1 SEC release, 6 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Xin Wang and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Xin Wang" (NJ) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.